(Q53144473)
Statements
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial. (English)
A Ferrero
G De Rauglaudre
P Vasey
A Reinthaller
E Pujade-Lauraine
N Reed
S Siena
H Helland
L Elit
S Mahner
5 October 2011
23
5
1185-1189